5 Results for "

human α2C adrenergic receptors

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "human α2C adrenergic receptors" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-12709
CAS No.: 67339-62-2
Purity:  99.71%
Research Areas:  

Neurological Disease

ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM .
loading...
    loading...
Cat. No.: HY-106444
CAS No.: 150586-58-6
Synonyms: MPV 1730; JP-1730
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

Fipamezole (MPV 1730; JP-1730) is a potent and orally active α2-adrenergic receptor antagonist with Ki values of 9.2 nM, 17 nM, and 55 nM for human α2A, α2B, and α2C, receptors, respectively. Fipamezole is an anti-dyskinetic agent, and can be used for the study of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-12709R
CAS No.: 67339-62-2
Research Areas:  

Neurological Disease

ARC 239 (Standard) is the analytical standard of ARC 239. This product is intended for research and analytical applications. ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM .
loading...
    loading...
Cat. No.: HY-106444A
CAS No.: 150586-72-4
Synonyms: MPV-1730 hydrochloride; JP-1730 hydrochloride
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

Fipamezole hydrochloride is a potent and orally active α2-adrenergic receptor antagonist with Ki values of 9.2 nM, 17 nM, and 55 nM for human α2A, α2B, and α2C, receptors, respectively. Fipamezole hydrochloride is an anti-dyskinetic agent, and can be used for the study of Parkinson's disease .
loading...
    loading...
Cat. No.: HY-121675A
CAS No.: 2855123-30-5
Synonyms: BOL-148 D-Tartrate; Bromolysergide D-Tartrate
2-Bromo-LSD D-Tartrate (BOL-148 D-Tartrate) is a blood-brain barrier-permeable 5-HT2A partial agonist and competitive partial antagonist. 2-Bromo-LSD D-Tartrate acts as both a potent partial agonist (with an EC50 of 0.81 nM for Gq dissociation) and a potent partial antagonist (with a KB of 0.18 nM for Gq dissociation) at the 5-HT2A receptor. 2-Bromo-LSD D-Tartrate exhibits partial agonist activity at multiple aminergic GPCRs, including 5-HT2A. 2-Bromo-LSD D-Tartrate lacks 5-HT2B agonist activity. 2-Bromo-LSD D-Tartrate induces dendritogenesis and spinogenesis. 2-Bromo-LSD D-Tartrate reverses the behavioral effects of chronic stress and increases active coping behaviors in mice .
loading...
    loading...